| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Baird William D III is a Chief Financial Officer at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $12.23 | $122,275.00 | -7.8% | |
| Jul 2, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $15.63 | $156,292.00 | -8.5% | |
| Apr 2, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $14.26 | $142,648.00 | -7.8% | |
| Jan 2, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $14.72 | $147,181.00 | -9.5% | |
| Oct 12, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 40,000 | $14.25 | $570,132.00 | -29.6% |